drugset / Trial / NCT00571506
Effect of Thiazolidinedione Treatment Vascular Risk Markers
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to examine the effects of two diabetes medications, rosiglitazone and pioglitazone, on markers of vascular disease in subjects with type 2 diabetes.
Timeline
- Start
- 2004-05
- Primary completion
- 2007-08
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pioglitazone | Small molecule | 30 mg | Oral |
| Subject | Rosiglitazone | Small molecule | 4 mg | Oral |